Pharmacological interactions between phenylbenzothiazoles and aryl hydrocarbon receptor (AhR)

QR Code

Pharmacological interactions between phenylbenzothiazoles and aryl hydrocarbon receptor (AhR)

The aryl hydrocarbon receptor is a ligand-dependent transcription factor that induces expression of a number of genes encoding drug metabolizing enzymes, such as CYP1A1, CYP1A2 and CYP1B1. Recently, it was suggested that the AhR signaling pathway may be involved in mediating the anticancer activity...

Full description

Bibliographic Details
Main Author:	Bazzi, Rana
Format:	Thesis (University of Nottingham only)
Language:	English
Published:	2008
Online Access:	https://eprints.nottingham.ac.uk/10999/

Similar Items

The induction of aryl hydrocarbon receptor (AHR) in immune organs of developing chicks by polycyclic aromatic hydrocarbons
by: Nisha, A. R., et al.
Published: (2018)

Recombinant expression of functional mouse AhR LBD in E. coli
by: Elhawari, Wail
Published: (2012)

Recombinant expression of the Aryl Hydrocarbon Receptor
by: Shaikh-Omar, Osama
Published: (2007)

Testing for partial agonism of the aryl hydrocarbon receptor
by: Wall, Richard J.
Published: (2008)

2-(4-Amino-3-methylphenyl)-5-fluorobenzothiazole is a ligand and shows species-specific partial agonism of the Aryl Hydrocarbon Receptor
by: Bazzi, Rana, et al.
Published: (2009)

Potency and species specificity of aryl hydrocarbon receptor ligands
by: Wall, Richard John
Published: (2012)

Characterisation of Recombinant Aryl Hydrocarbon Receptor Ligand Binding Domain
by: Jiang, Tao
Published: (2004)

Expression of the Caenorhabditis elegans aryl hydrocarbon receptor ligand binding domain
by: Helaly, Ahmed
Published: (2011)

Recombinant expression of Aryl Hydrocarbon Receptor for quantitative ligand-binding analysis
by: Fan, MingQi, et al.
Published: (2009)

Naturally-occurring glucosinolates, glucoraphanin and glucoerucin, are antagonists to aryl hydrocarbon receptor as their chemopreventive potency
by: Abdull Razis, Ahmad Faizal, et al.
Published: (2015)

A truncation in the Aryl Hydrocarbon Receptor of the CRL:WI(Han) rat does not affect the developmental toxicity of TCDD
by: Jiang, tao, et al.
Published: (2009)

Characterisation of chlorinated, brominated and mixed halogenated dioxins, furans and biphenyls as potent and as partial agonists of the Aryl hydrocarbon receptor
by: Wall, Richard J., et al.
Published: (2015)

The mannose receptor negatively modulates the Toll-like receptor 4–aryl hydrocarbon receptor–indoleamine 2,3-dioxygenase axis in dendritic cells affecting T helper cell polarization
by: Salazar, Fabián, et al.
Published: (2016)

The role of indoleamine 2,3-dioxygenase-aryl hydrocarbon receptor pathway in the TLR4-induced tolerogenic phenotype in human DCs
by: Salazar, Fabián, et al.
Published: (2017)

Analysis of UAV state estimation modeling based on AHRS and INS configurations
by: Mohd Razali, Noor Ashikin, et al.
Published: (2017)

Selective C-arylation of 2,5-dibromo-3-hexylthiophene via Suzuki cross coupling reaction and their pharmacological aspects
by: Ikram, Hafiz Mansoor, et al.
Published: (2015)

An evaluation of DREADD receptor pharmacology in recombinant cells and astrocytes
by: Carpenter, Jessica
Published: (2020)

Kinetic studies of dopamine D2 receptor molecular pharmacology
by: Keen, Alastair C.
Published: (2021)

Synthesis of quaternary aryl phosphonium salts: photoredox-mediated phosphine arylation
by: Fearnley, A.F., et al.
Published: (2016)

Bismuth-mediated arylation
by: Jurrat, Mark
Published: (2019)

Arylation with Bismuthonium Salts
by: Maggi, Lorenzo
Published: (2021)

Solute–solvent interactions mediated by main group element(lone-pair)···π(aryl) interactions
by: Tiekink, Edward R. T. *, et al.
Published: (2017)

Pharmacological characterisation of the fatty acid receptors GPR120 and FFA1
by: Watson, Sarah-Jane
Published: (2013)

In vitro antitumor effects of AHR ligands aminoflavone (AFP 464) and benzothiazole (5F 203) in human renal carcinoma cells
by: Luzzani, Gabriela A., et al.
Published: (2017)

Binuclear phosphanegold(I) thiocarbamates: The importance of Au···π(aryl) interactions and their antimicrobial activity
by: Yeo, Chien Ing *
Published: (2016)

Design, synthesis and pharmacological evaluation of novel fluorescent ligands for the mu-opioid receptor
by: Marshall, William
Published: (2021)

Angiotensin receptor neprilysin inhibitor LCZ696: Pharmacology, pharmacokinetics and clinical development
by: Hua, Y., et al.
Published: (2017)

Selective arylation of phenol protected propygyl bromide via pd-catalysed Suzuki coupling reaction: synthesis, mechanistic studies by DFT calculations and their pharmacological aspects
by: Farooq, Hira, et al.
Published: (2018)

Bismuth(V) mediated meta-arylation
by: Senior, Aaron James
Published: (2022)

Bismuth-Mediated Arylation of Weak Nucleophiles
by: Ruffell, Katie
Published: (2023)

Nickel-catalysed enantioselective arylative cyclisations
by: Clarke, Christopher
Published: (2019)

Pharmacological analysis and structure determination of 7-methylcyanopindolol–bound b1-adrenergic receptor
by: Sato, Tomomi, et al.
Published: (2015)

NanoBRET to probe ligand-receptor and receptor-receptor interactions in living cells
by: Carvalheira Alcobia, Diana
Published: (2019)

Stereoselective nickel-catalysed arylative cyclisation reactions
by: Panchal, Heena
Published: (2019)

Molecular pharmacological studies of CHFI-FXII interaction and FXII function
by: Kareem Hamad, B.
Published: (2016)

The preclinical efficacy, selectivity and pharmacologic profile of MK-5932, an insulin-sparing selective glucocorticoid receptor modulator
by: Brandish, P., et al.
Published: (2014)

Synthesis of pyrroles by nickel-catalysed arylative cyclisations of alkynamides
by: Chung, Chieh-Hsu
Published: (2019)

Advances in Bismuth-Mediated Arylation and Phosphorus Redox Catalysis
by: Calcatelli, Alessio
Published: (2025)

The study of the reaction of morpholine with aryl halide and aliphatic halide
by: Dorairaaj, A/L Sivasubramaniam
Published: (2013)

A G protein-coupled receptor dimer imaging assay reveals selectively modified pharmacology of neuropeptide Y Y1/Y5 receptor heterodimers
by: Kilpatrick, Laura E., et al.
Published: (2015)